The priorities are infrastructure, accounting for 40%, and technology, accounting for 25%. Our approach to everything is very systemic. With regards technology, for example, we have built seven partnerships with the world’s leading countries. This enables us to look at technology in Russia, and immediately be able to say whether it is a globally competitive product or not. — Kirill Dmitriev, Chief Executive Officer, Russian Direct Investment Fund (RDIF).
We have become leaders in the genetically engineered insulin market, and plan to become the leader in the entire diabetes market in the next few years. This will provide an enormous opportunity to make all medications, treatments, and diagnoses of diabetes <...> far more accessible, with production based entirely in Russia. — Petr Rodionov, General Director, Geropharm.
We made our deal with the RDIF last year. <...> Thanks to that organization and partners, six sovereign wealth funds became company shareholders. <...> We moved to a free float of 25%, and improved our index weight. <...> Turnover on our shares increased five-fold on the Moscow Exchange. — Andrey Guryev, Chief Executive Officer, Chairman of the Management Board, PhosAgro .
Our objective <...> is to create a new technological wave. <...> We must develop our technologies, and then take them to the global market. — Andrey Kuzyaev, President, ER-Telecom Holding .
In order to make a breakthrough in the future, we hope that sooner or later the city of St. Petersburg will obtain free port status. <...> I would like to see an expansion of the practice of visa-free regimes. — .